Literature DB >> 26921944

Dual-Color Luciferase Complementation for Chemokine Receptor Signaling.

Kathryn E Luker1, Gary D Luker2.   

Abstract

Chemokine receptors may share common ligands, setting up potential competition for ligand binding, and association of activated receptors with downstream signaling molecules such as β-arrestin. Determining the "winner" of competition for shared effector molecules is essential for understanding integrated functions of chemokine receptor signaling in normal physiology, disease, and response to therapy. We describe a dual-color click beetle luciferase complementation assay for cell-based analysis of interactions of two different chemokine receptors, CXCR4 and ACKR3, with the intracellular scaffolding protein β-arrestin 2. This assay provides real-time quantification of receptor activation and signaling in response to chemokine CXCL12. More broadly, this general imaging strategy can be applied to quantify interactions of any set of two proteins that interact with a common binding partner.
© 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bioluminescence; Molecular imaging; Optical imaging; Protein fragment complementation; Split luciferase

Mesh:

Substances:

Year:  2015        PMID: 26921944      PMCID: PMC5245831          DOI: 10.1016/bs.mie.2015.08.024

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  13 in total

1.  Monitoring protein-protein interactions using split synthetic renilla luciferase protein-fragment-assisted complementation.

Authors:  R Paulmurugan; S S Gambhir
Journal:  Anal Chem       Date:  2003-04-01       Impact factor: 6.986

Review 2.  Dissection of aberrant GPCR signaling in tumorigenesis--a systems biology approach.

Authors:  Jinhua Wu; Na Xie; Xia Zhao; Edouard C Nice; Canhua Huang
Journal:  Cancer Genomics Proteomics       Date:  2012-01       Impact factor: 4.069

3.  A highly sensitive protein-protein interaction assay based on Gaussia luciferase.

Authors:  Ingrid Remy; Stephen W Michnick
Journal:  Nat Methods       Date:  2006-11-12       Impact factor: 28.547

Review 4.  Fluorescent and bioluminescent protein-fragment complementation assays in the study of G protein-coupled receptor oligomerization and signaling.

Authors:  Pierre-Alexandre Vidi; Val J Watts
Journal:  Mol Pharmacol       Date:  2009-01-13       Impact factor: 4.436

Review 5.  Linkers in the structural biology of protein-protein interactions.

Authors:  Vishnu Priyanka Reddy Chichili; Veerendra Kumar; J Sivaraman
Journal:  Protein Sci       Date:  2013-01-08       Impact factor: 6.725

6.  Beta-arrestin- but not G protein-mediated signaling by the "decoy" receptor CXCR7.

Authors:  Sudarshan Rajagopal; Jihee Kim; Seungkirl Ahn; Stewart Craig; Christopher M Lam; Norma P Gerard; Craig Gerard; Robert J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-17       Impact factor: 11.205

7.  Imaging CXCR4 signaling with firefly luciferase complementation.

Authors:  Kathryn E Luker; Mudit Gupta; Gary D Luker
Journal:  Anal Chem       Date:  2008-06-06       Impact factor: 6.986

8.  Kinetics of regulated protein-protein interactions revealed with firefly luciferase complementation imaging in cells and living animals.

Authors:  Kathryn E Luker; Matthew C P Smith; Gary D Luker; Seth T Gammon; Helen Piwnica-Worms; David Piwnica-Worms
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-29       Impact factor: 11.205

9.  In vivo imaging of ligand receptor binding with Gaussia luciferase complementation.

Authors:  Kathryn E Luker; Laura Anne Mihalko; Bradley T Schmidt; Sarah A Lewin; Paramita Ray; Dmitry Shcherbo; Dmitriy M Chudakov; Gary D Luker
Journal:  Nat Med       Date:  2011-12-04       Impact factor: 53.440

10.  A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development.

Authors:  Jennifer M Burns; Bretton C Summers; Yu Wang; Anita Melikian; Rob Berahovich; Zhenhua Miao; Mark E T Penfold; Mary Jean Sunshine; Dan R Littman; Calvin J Kuo; Kevin Wei; Brian E McMaster; Kim Wright; Maureen C Howard; Thomas J Schall
Journal:  J Exp Med       Date:  2006-08-28       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.